Preferred Dental Technologies Inc. Continues Investigating Brazil Licensing Opportunity in Sao Paulo

Winnipeg, MB - TheNewswire - August 21, 2019 - Preferred Dental Technologies Inc. (CNSX:PDTI.CN)(OTC:PDTTF) takes this opportunity to wish one of our Team Members safe travels as he heads to Sao Paulo, Brazil today to attend IN 2019 - the Latin American Osseointegration Congress which is the largest meeting of implantology in Latin America currently being held from August 22-24, 2019. One reason we send representatives to major conferences such as IN 2019 is to keep up to date on upcoming products and services which may be potential competition for the EAS System in the dental implant landscape, as well as to seek out potential distributors. To date, no other product line has the full suite of features offered by the EAS System.


Link to IN 2019 https://www.in2019.com.br/


There have been some developments and changes since the last major update on our foreign market initiatives. Previously, we were in talks with representatives from a major Brazilian dental company over licensing opportunities for the EAS System, PDTI's patented abutment components for dental implants. Internally, we set this particular opportunity to have a deadline of August 2019, where we would then consider opportunities with other distributors. Brazilian dentists who were introduced to the system have been speaking to their peers and associates which has resulted in four additional Brazilian companies indicating their interest in distribution rights for the system.


These companies have had the chance to learn about the EAS System and have expressed an interest in further discussions. The IN 2019 Conference provides a great opportunity to meet with them all in one location. Our team member will be spending a month in Brazil, allowing opportunities for in-person follow ups and discussions as we endeavor to produce initial terms of a deal to the Board of Directors before the end of September.

Brazil is the third largest global market for dental implants and remains one of the fastest growing markets worldwide with 15% of the world's dentists working there, continuing to be an area of strong strategic importance to dental implant companies.


CEO Erik Siegmund said, "Brazil remains a huge foreign market opportunity for PDTI, and thanks to our Board of Advisors who have first-hand knowledge of the country and the dental market there, it is one within our reach. Brazil remains a key strategic market for any major implant company, and as a result of technology and being able to adapt to local conditions, PDTI possesses a product ideal for the region which is a unique offering for a company of our size. We knew the opportunity was significant when representatives from one of Brazil's major companies flew to Winnipeg to further discuss licensing, but it was validated when four other companies expressed interest shortly thereafter. Because of Brazilian regulations, it is very important that we find the right partner to bring the EAS System to Brazil, and our options have just become greater as we examine each opportunity carefully to maximize the value a deal would bring to PDTI shareholders."


About PDTI

Preferred Dental Technologies Inc. (PDTI) has been established to advance development and commercialization of various evolutionary and disruptive technologies in the dental implant industry.


MISSION - INNOVATIVE & PRACTICAL SOLUTIONS FOR THE DENTAL INDUSTRY


Visit: www.prefdent.com

On behalf of Preferred Dental Technologies Inc.

Erik Siegmund

Chief Executive Officer

Email: info@prefdent.com

Tel: 204.691.3722

www.prefdent.com


All product names referenced herein are trademarks of their respective companies.

This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the Company's objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company's public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither The Canadian Securities Exchange nor its Regulations Services Provider (as that term is defined in the policies of The Canadian Securities Exchange accepts any responsibility for the adequacy or accuracy of this release.


#DentalImplants #DentalAbutments #DentalTechnology #HealthandWellness #Dentistry #InvestinginHealth #CBD #Cannabis #InvestinginCannabis #CannabisStocks #SmallCapStocks #FrontierMCG

Recent Posts

See All

Toronto | Montreal | Calgary | Vancouver

https://www.frontiermcg.com